These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32025385)

  • 1. Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon.
    Malik BH; Hamid P; Khan S; Gupta D; Islam M
    Cureus; 2019 Dec; 11(12):e6451. PubMed ID: 32025385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval prolongation and
    Malone K; Hancox JC
    Ther Adv Drug Saf; 2020; 11():2042098620942416. PubMed ID: 32874532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil-induced torsades de pointes without QT prolongation.
    Hadano Y; Ogawa H; Wakeyama T; Iwami T; Kimura M; Mochizuki M; Akashi S; Miyazaki Y; Nakashima T; Shimizu A
    J Cardiol Cases; 2013 Aug; 8(2):e69-e71. PubMed ID: 30546746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of donepezil-related torsades de pointes.
    Kitt J; Irons R; Al-Obaidi M; Missouris C
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Generation Antipsychotic Drugs and QTc Interval Prolongation.
    Vieweg WV
    Prim Care Companion J Clin Psychiatry; 2003 Oct; 5(5):205-215. PubMed ID: 15213787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
    Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
    Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesson of the month 1: Prolonged QT syndrome due to donepezil: a reversible cause of falls?
    Jackson EG; Stowe S
    Clin Med (Lond); 2019 Jan; 19(1):80-81. PubMed ID: 30651253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Torsades de pointes" and atrioventricular block.
    Moroe K; Saku K; Tashiro N; Hiroki T; Arakawa K
    Clin Cardiol; 1988 Jan; 11(1):9-13. PubMed ID: 3349663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ventricular ectopy precedes Torsades de Pointes in patients with prolonged QT.
    Marill KA; Lopez S; Hark D; Spahr J; Kapadia N; Liu SW
    J Electrocardiol; 2023; 80():17-23. PubMed ID: 37105125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Torsades de Pointes: a cause of syncope in sinus node dysfunction].
    Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S
    Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.
    Tisdale JE
    Can Pharm J (Ott); 2016 May; 149(3):139-52. PubMed ID: 27212965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cases of drug-induced Torsade de Pointes: a review of Belgian cases in the EudraVigilance database.
    Vandael E; Vandenberk B; Vandenberghe J; Willems R; Foulon V
    Acta Clin Belg; 2017 Dec; 72(6):385-390. PubMed ID: 28335691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.